Search

Your search keyword '"Van Tine, Brian A"' showing total 812 results

Search Constraints

Start Over You searched for: Author "Van Tine, Brian A" Remove constraint Author: "Van Tine, Brian A"
812 results on '"Van Tine, Brian A"'

Search Results

1. The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer.

4. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

6. A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.

7. Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma

9. Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

10. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

12. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

13. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

14. Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.

15. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

19. Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

20. A phase 2 study of a brachyury‐targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.

22. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

23. Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update

26. Abstract B112: A dose escalation and cohort expansion study of the CDK9 inhibitor KB-0742 in relapsed, refractory ovarian cancer and transcriptionally addicted relapsed or refractory solid tumors

30. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

33. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

35. Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma

39. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research

42. Atezolizumab for Advanced Alveolar Soft Part Sarcoma

43. Contributors

45. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

46. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

47. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

48. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

49. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

50. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

Catalog

Books, media, physical & digital resources